Elucidating Mechanisms of Pregnancy's Protective Effect on Drug Abuse Using Integrated Data Analysis
利用综合数据分析阐明怀孕对药物滥用的保护作用机制
基本信息
- 批准号:10357793
- 负责人:
- 金额:$ 56.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-01 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdoptionAttenuatedAwarenessCharacteristicsChildChild RearingClinicalCodeCognitionCognitiveComplexConceptionsDataData AnalysesData SetDevelopmentDevelopmental ProcessDrug ExposureDrug abuseDrug usageEpidemiologistEpidemiologyEventExperimental DesignsFailureFoundationsFutureGoalsGoldIndividualInterruptionInterventionInterviewInvestigationInvestmentsKnowledgeLinkLongevityMeasuresMediator of activation proteinMethodologyMothersMultiple PregnancyNational Institute of Drug AbuseNatureOutcomeParentsPathway interactionsPatternPersonsPharmaceutical PreparationsPregnancyPregnant WomenPreventionProcessPsychiatristPublic HealthRiskRoleSamplingScientistSecond Pregnancy TrimesterSmokerSmokingSmoking BehaviorSmoking Cessation InterventionSocial ProcessesSubstance abuse problemTestingTimeTo specifyTobaccoWomanWorkaddictionbasebehavior changecardiovascular disorder preventioncaregivingchild bearingcigarette smokingcohortdesignexperiencefetal tobacco exposurefinancial incentiveimprovedinnovationinsightnoveloffspringperson centeredprecision medicineprenatalprenatal exposureprenatal interventionprotective effectpsychosocialsmoking cessationsmoking during pregnancysocialsubstance usetherapy designtoolunborn child
项目摘要
PROJECT SUMMARY/ABSTRACT
The notable protective effect of pregnancy on women’s tobacco and other drug use is a common yet
understudied phenomenon in which addictive processes are temporarily attenuated in the absence of
treatment. Identifying underlying mechanisms would provide novel insights into how addictive processes could
be more effectively disrupted.
To accelerate progress towards this goal and overcome methodologic limitations of prior studies, we
repurpose multiple existing datasets with unique features to accomplish our aims. Specifically, we will:
1. Utilize a within-person design to estimate the unique “effect” of pregnancy, and salient events of
pregnancy, on smoking behavior within a single pregnancy.
2. Isolate and estimate the impact of general and parenting-related developmental influences on smoking by
examining between-pregnancy differences in a subset of women who were assessed on two pregnancies.
3. Examine the role of prenatal reflective functioning, coded from existing gold-standard qualitative interviews,
in pregnancy’s protective effect on smoking.
Aims 1 & 2 will provide the first ever estimates of precisely when and how pregnancy interacts with smoking
behavior, setting the stage for future work to specify novel intervention targets. As reflective functioning is
known to be malleable in substance using pregnant women, understanding its role in pregnancy-associated
change in smoking will provides the foundation for novel smoking cessation interventions.
This innovative proposal blends hypotheses generated from Dr. Massey’s (MPI) day-to-day clinical work as
an addiction psychiatrist with the cutting-edge quantitative and methodological expertise necessary to
rigorously test these hypotheses provided by epidemiologist Dr. Allen (MPI). Cohorts to be integrated contain
short-term (within pregnancy) and long-term (across multiple pregnancies) longitudinal data, state-of-the-art
drug exposure measures, and both qualitative and quantitative maternal data contributed by an experienced
team of established developmental scientists: Drs. Neiderhiser (Co-I), Eiden (Co-I), and Wakschlag (Co-I).
As data were originally developed with NIDA’s support to examine drug-exposed children, they are
uniquely suited to examine drugs alone, and in combination. Knowledge from this study is needed to improve
and personalize prenatal interventions and to guide future investigations of exposure-related offspring
outcomes. Elucidating mechanisms underlying pregnancy’s protective effect on drug use also informs a
broader understanding of how social processes successfully compete with addictive processes.
项目概要/摘要
怀孕对女性吸烟和其他药物使用具有显着的保护作用,这是一个常见的现象
尚未充分研究的现象,即成瘾过程在缺乏药物的情况下暂时减弱
治疗。识别潜在机制将为成瘾过程如何发挥作用提供新的见解
受到更有效的干扰。
为了加速实现这一目标并克服先前研究的方法学局限性,我们
重新利用多个具有独特功能的现有数据集来实现我们的目标。具体来说,我们将:
1. 利用内部设计来估计怀孕的独特“影响”以及怀孕期间的显着事件
怀孕期间的吸烟行为。
2. 分离并估计一般和养育相关的发育影响对吸烟的影响
检查对两次怀孕进行评估的一部分妇女的怀孕间差异。
3. 检查产前反思功能的作用,根据现有的黄金标准定性访谈进行编码,
怀孕对吸烟的保护作用。
目标 1 和 2 将首次准确估计怀孕何时以及如何与吸烟相互作用
行为,为未来工作确定新的干预目标奠定基础。由于反思功能是
已知对孕妇具有可塑性的物质,了解其在妊娠相关的作用
吸烟的变化将为新型戒烟干预措施奠定基础。
这项创新提案融合了 Massey 博士 (MPI) 日常临床工作中产生的假设:
成瘾精神病学家,拥有必要的尖端定量和方法专业知识
严格检验流行病学家 Allen 博士 (MPI) 提供的这些假设。要整合的队列包含
短期(怀孕期间)和长期(多次怀孕)纵向数据,最先进的
药物暴露测量,以及由经验丰富的母亲提供的定性和定量数据
成熟的发展科学家团队:博士。 Neiderhiser (Co-I)、Eiden (Co-I) 和 Wakschlag (Co-I)。
由于数据最初是在 NIDA 的支持下开发的,用于检查接触药物的儿童,因此它们是
非常适合单独和组合检查药物。需要从这项研究中获得知识来改进
个性化产前干预并指导未来对暴露相关后代的调查
结果。阐明妊娠对药物使用的保护作用的潜在机制也为研究提供了信息。
更广泛地了解社会过程如何成功地与成瘾过程竞争。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Suena Huang Massey其他文献
Suena Huang Massey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Suena Huang Massey', 18)}}的其他基金
Elucidating Mechanisms of Pregnancy's Protective Effect on Drug Abuse Using Integrated Data Analysis
利用综合数据分析阐明怀孕对药物滥用的保护作用机制
- 批准号:
10758397 - 财政年份:2021
- 资助金额:
$ 56.79万 - 项目类别:
Cognitive-Affective Substrates of Smoking: Targets for Maternal Behavior Change
吸烟的认知情感基础:母亲行为改变的目标
- 批准号:
9096060 - 财政年份:2015
- 资助金额:
$ 56.79万 - 项目类别:
Cognitive-Affective Substrates of Smoking: Targets for Maternal Behavior Change
吸烟的认知情感基础:母亲行为改变的目标
- 批准号:
9416374 - 财政年份:2015
- 资助金额:
$ 56.79万 - 项目类别:
Cognitive-Affective Substrates of Smoking: Targets for Maternal Behavior Change
吸烟的认知情感基础:母亲行为改变的目标
- 批准号:
8890544 - 财政年份:2015
- 资助金额:
$ 56.79万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 56.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 56.79万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 56.79万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 56.79万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 56.79万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 56.79万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 56.79万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 56.79万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 56.79万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 56.79万 - 项目类别:
Idea to Innovation














{{item.name}}会员




